AB Science S.A./€AB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About AB Science S.A.
AB Science S.A. is a biotechnology company based in Paris, France, specializing in the research, development, and commercialization of protein kinase inhibitors. These are used in the treatment of cancers, chronic inflammatory diseases, and neurodegenerative disorders. Established in 2001, the company targets diseases with significant unmet medical needs through proprietary compounds, notably masitinib which is in various stages of clinical trials. AB Science operates primarily in Europe and has various products in its pipeline aimed at both human and veterinary medicine. Its strategic focus on niche therapeutic areas where there are few treatment options gives it a distinct position in the pharmaceutical industry.
Ticker
€AB
Sector
Primary listing
PAR
Industry
Pharmaceuticals
Headquarters
Employees
34
ISIN
FR0010557264
Website
AB Science S.A. Metrics
BasicAdvanced
€97M
-
-€0.15
1.57
-
Price and volume
Market cap
€97M
Beta
1.57
52-week high
€2.34
52-week low
€0.77
Average daily volume
168K
Financial strength
Current ratio
0.711
Quick ratio
0.66
Long term debt to equity
-61.223
Total debt to equity
-77.76
Interest coverage (TTM)
-2.51%
Profitability
EBITDA (TTM)
-5.689
Gross margin (TTM)
116.42%
Net profit margin (TTM)
-730.50%
Operating margin (TTM)
-567.44%
Revenue per employee (TTM)
€30,000
Management effectiveness
Return on assets (TTM)
-15.62%
Return on equity (TTM)
34.99%
Valuation
Price to revenue (TTM)
70.91
Price to book
-3.96
Price to tangible book (TTM)
-3.75
Price to free cash flow (TTM)
209.647
Free cash flow yield (TTM)
0.48%
Free cash flow per share (TTM)
0.69%
Growth
Revenue change (TTM)
10.52%
Earnings per share change (TTM)
-37.84%
3-year revenue growth (CAGR)
-12.62%
10-year revenue growth (CAGR)
-6.50%
3-year earnings per share growth (CAGR)
-21.01%
10-year earnings per share growth (CAGR)
-11.15%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AB Science S.A. stock?
AB Science S.A. (AB) has a market cap of €97M as of July 04, 2025.
What is the P/E ratio for AB Science S.A. stock?
The price to earnings (P/E) ratio for AB Science S.A. (AB) stock is 0 as of July 04, 2025.
Does AB Science S.A. stock pay dividends?
No, AB Science S.A. (AB) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next AB Science S.A. dividend payment date?
AB Science S.A. (AB) stock does not pay dividends to its shareholders.
What is the beta indicator for AB Science S.A.?
AB Science S.A. (AB) has a beta rating of 1.57. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.